This company listing is no longer active
7LV0 Stock Overview
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
The Valens Company Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.69 |
| 52 Week High | CA$2.58 |
| 52 Week Low | CA$0.54 |
| Beta | 1.79 |
| 1 Month Change | 11.55% |
| 3 Month Change | 6.27% |
| 1 Year Change | -58.59% |
| 3 Year Change | -91.33% |
| 5 Year Change | -85.41% |
| Change since IPO | -63.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7LV0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 5.3% | 2.7% | 1.8% |
| 1Y | -58.6% | -24.4% | 5.7% |
Return vs Industry: 7LV0 underperformed the German Pharmaceuticals industry which returned 2.3% over the past year.
Return vs Market: 7LV0 underperformed the German Market which returned -13% over the past year.
Price Volatility
| 7LV0 volatility | |
|---|---|
| 7LV0 Average Weekly Movement | 11.4% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7LV0's share price has been volatile over the past 3 months.
Volatility Over Time: 7LV0's weekly volatility has decreased from 17% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 445 | n/a | https://www.thevalenscompany.com |
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space.
The Valens Company Inc. Fundamentals Summary
| 7LV0 fundamental statistics | |
|---|---|
| Market cap | €56.06m |
| Earnings (TTM) | -€161.67m |
| Revenue (TTM) | €58.96m |
1.0x
P/S Ratio-0.3x
P/E RatioIs 7LV0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7LV0 income statement (TTM) | |
|---|---|
| Revenue | CA$85.89m |
| Cost of Revenue | CA$88.93m |
| Gross Profit | -CA$3.03m |
| Other Expenses | CA$232.49m |
| Earnings | -CA$235.52m |
Last Reported Earnings
Aug 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.91 |
| Gross Margin | -3.53% |
| Net Profit Margin | -274.21% |
| Debt/Equity Ratio | 75.7% |
How did 7LV0 perform over the long term?
See historical performance and comparison